Metastatic Melanoma With Leptomeningeal Disease

Leptomeningeal disease in patients with melanoma historically portends a grim prognosis, with median survival measured in weeks to months. The advent of effective immunotherapy and targeted agents may modify the outcome of such patients. This case report describes a 43-year-old patient diagnosed wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Marinova, Amanda M., Reilly, Jennifer L., Wong, Victoria, Weiss, Stephanie, Olszanski, Anthony J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2021
Materias:
Grand Rounds
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844196/
https://www.ncbi.nlm.nih.gov/pubmed/33552663
http://dx.doi.org/10.6004/jadpro.2021.12.1.6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844196/
https://www.ncbi.nlm.nih.gov/pubmed/33552663
http://dx.doi.org/10.6004/jadpro.2021.12.1.6

Ejemplares similares